This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n6http://dx.doi.org/10.1191/

Statements

Subject Item
wd:Q44754581
rdf:type
wikibase:Item
schema:description
artikull shkencor articolo scientifico vitenskapelig artikkel scienca artikolo 2004년 논문 videnskabelig artikel 2004年學術文章 artigo científico article scientific article científic научная статья 2004年學術文章 სამეცნიერო სტატია 2004年學術文章 vitskapeleg artikkel 2004年學術文章 2004年の論文 مقالة علمية نشرت في فبراير 2004 научни чланак tieteellinen artikkeli naučni članak επιστημονικό άρθρο artikulong pang-agham article scientifique научни чланак 2004年学术文章 vedecký článok teaduslik artikkel 2004年学术文章 artículu científicu scientific article published in February 2004 2004年學術文章 2004年学术文章 artículo científico publicado en 2004 wissenschaftlicher Artikel ফেব্রুয়ারি ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel bài báo khoa học articol științific artigo científico บทความทางวิทยาศาสตร์ vědecký článek tudományos cikk научна статия bilimsel makale מאמר מדעי 2004年学术文章 2004年学术文章 scientific article published in February 2004 artigo científico wetenschappelijk artikel 2004年学术文章 scientific article published in February 2004 наукова стаття, опублікована в лютому 2004 мақолаи илмӣ artikel ilmiah 2004 nî lūn-bûn artykuł naukowy
p:P577
wds:Q44754581-D0394B1C-FA48-4676-9079-6539CFDED940
wdt:P577
2004-02-01T00:00:00Z
p:P407
wds:Q44754581-BC74FF1A-B991-4193-BF2D-0B6805A8E0EB
wdt:P407
wd:Q1860
p:P2860
wds:Q44754581-E8867225-FCF9-42F9-84AE-CA301C42F842 wds:Q44754581-339EB265-6DFD-43D3-92BD-C33A82C3F4BE wds:Q44754581-A45D2152-0DBE-40D2-B3E7-F5EB318B3B5D wds:Q44754581-AF6A226D-EA52-4D89-8EE7-2B1E098544CE wds:Q44754581-693104DB-AF39-4470-8116-4B173895512C wds:Q44754581-C9C3084C-AC11-4129-84DC-66462601EF65 wds:Q44754581-1110C202-BDDF-4D9C-AB57-7D2EB0CC2DA8
wdt:P2860
wd:Q36898147 wd:Q33739595 wd:Q57416513 wd:Q34253953 wd:Q22241644 wd:Q52364596 wd:Q29616022
p:P2093
wds:Q44754581-4EB77171-885E-40D6-9263-76270B9F29F0 wds:Q44754581-1AA76342-4950-4443-89D8-41A4AB901DCC wds:Q44754581-105CCCDA-AB07-4907-B47D-BBE36061D0B5 wds:Q44754581-0C4C8084-4549-4DD2-810F-6147416A12DA wds:Q44754581-EDC9DB65-0500-42E6-AF57-89CA0AA64E2A wds:Q44754581-9F013E52-6EC4-4D33-8411-BFA9EC89959C wds:Q44754581-8497A729-18E2-41E1-8F61-C9A800427891
wdt:P2093
L H Visser R Beekman C C Tijssen K L L Movig M L Lee B M J Uitdehaag A W Lenderink
rdfs:label
A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
skos:prefLabel
A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
schema:name
A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
p:P1476
wds:Q44754581-6D732B9A-6AB7-4AF0-9743-5AB3C074B37E
wdt:P1476
A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
p:P304
wds:Q44754581-AFF38864-83CD-4708-99C5-AE8F9161C2AF
wdt:P304
89-91
p:P31
wds:Q44754581-0FA4F885-FC04-48A9-AEFD-5357B58BAAD6
wdt:P31
wd:Q13442814
p:P921
wds:Q44754581-76DAFACC-281E-4298-B5D2-DA03BE7DD0C7 wds:Q44754581-F0466257-DBAE-443D-876B-670D3ECD4086
wdt:P921
wd:Q269829 wd:Q417222
p:P698
wds:Q44754581-61C61C4C-C287-48A3-87E6-3D4F072C6241
wdtn:P698
n9:14760960
wdt:P698
14760960
p:P1433
wds:Q44754581-1110503A-89BC-45CE-AA24-5AFC78B17064
wdt:P1433
wd:Q1952449
p:P433
wds:Q44754581-47262154-5CA2-4CE4-9D66-AFCFD7D37D29
p:P478
wds:Q44754581-392D7471-9018-4940-AFDD-A2B885BD72A5
wdt:P433
1
wdt:P478
10
p:P356
wds:Q44754581-43747043-1579-402B-8FB6-2D6559F56075
wdtn:P356
n6:1352458504MS978SR
wdt:P356
10.1191/1352458504MS978SR